The field of mitral valve disease diagnosis and management is rapidly changing. New
understanding of disease pathology and progression, with improvements in and increased …

Surgical and interventional management of mitral valve regurgitation: a position statement
from the European Society of Cardiology Working Groups on Cardiovascular Surgery and …

Objectives: The goal of this study was to compare survival between transcatheter mitral
valve (MV) repair using MitraClip system (Abbott Vascular, Santa Clara, California), MV …

Background MitraClip implantation has emerged as a viable option in high surgical risk
patients with severe mitral regurgitation (MR). We performed the present systematic review …

Background Understanding the operative outcomes of mitral valve (MV) surgery across the
spectrum of predicted risk of mortality (PROM) is necessary to determine the best use of …

Background The optimal treatment of patients with severe mitral regurgitation (MR) at high
surgical risk (HSR) is unknown. Recently, the EVEREST II (Endovascular Valve Edge‐to …

Mitral regurgitation (MR) is the most common valve disease in the United States. However, a
significant number of patients are denied surgery due to increased age, poor ventricular …

Background—Survival outcome after MitraClip treatment, compared with surgical or
conservative treatment, is not well defined. We examined survival after MitraClip treatment in …

Background Estimating the quantitative effect of transcatheter mitral valve repair on
functional parameters and quality of life is important for individual treatment decision …

Percutaneous edge-to-edge repair using the MitraClip system causes reduction in mitral
valve area (MVA). However, its clinical impact is not fully elucidated. This study assessed the …